Acne And Related Disorders - Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report also reviews key players involved in the therapeutic development for Acne And Related Disorders. Acne And Related Disorders - Pipeline Review, Half Year is built using data and information sourced from publisher proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by publisher team.
Scope
- A snapshot of the global therapeutic scenario for Acne And Related Disorders.
- A review of the Acne And Related Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Acne And Related Disorders pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Acne And Related Disorders.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Acne And Related Disorders pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Spanning over 72 pages, 27 tables and 13 figures, “Acne And Related Disorders - Pipeline Review, H2 2013” report provides information on the therapeutic development for Acne And Related Disorders, complete with latest updates, and special features on late-stage and discontinued projects.
In addition to covering the Acne And Related Disorders Overview, Acne And Related Disorders Therapeutics under Development by Companies, Acne And Related Disorders Therapeutics under Investigation by Universities/Institutes, Mid Clinical Stage Products, Early Clinical Stage Products, Discovery and Pre-Clinical Stage Products, Companies Involved in Acne And Related Disorders Therapeutics Development, Acne And Related Disorders Therapeutics - Drug Profile Updates, Acne And Related Disorders Therapeutics - Dormant Products, Acne And Related Disorders - Product Development Milestones. The report covers 11 companies QLT Inc., Merz GmbH & Co. KGaA, Paratek Pharmaceuticals, Inc., Helix BioMedix, Inc., Phynova Group Ltd, Syntopix Group Plc, Novabiotics Ltd, Xenon Pharmaceuticals Inc., NovaLead Pharma Pvt. Ltd., Mimetica Pty Ltd. and Fibrocell Sciences, Inc.
Find all healthcare market research reports under a single page at: Healthcare Market Research Reports
No comments:
Post a Comment
Note: only a member of this blog may post a comment.